Navigation Links
Joachim Schorr, PhD, Named Chief Scientific Officer at Caris Life Sciences
Date:3/5/2013

IRVING, Texas, March 5, 2013 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, announced today that it has named Joachim Schorr , PhD, as its Chief Scientific Officer. He joins Caris in this role after working as a consultant with the company during the past year. In this expanded capacity, Dr. Schorr's extensive expertise in the molecular sciences arena will help to shape and advance Caris' research and development strategy.

"Having worked closely with Caris Life Sciences in 2012 as Senior Scientific Advisor, I have seen firsthand the world-class work being done every day at Caris to advance innovation in the field of personalized medicine," said Dr. Schorr. "Given our position as the emerging standard for cancer tumor profiling with the Molecular Intelligence Service, I am convinced that Caris is set to transform cancer diagnosis and patient care through its blood-based Carisome platform. I am excited to be part of this scientific paradigm shift."

Before joining Caris, Dr. Schorr held various leadership positions at QIAGEN N.V., the global leader in sample and assay Technologies, until April 2012. In his most recent role there, he served as Senior Vice President Global R&D and Managing Director, was a member of the Executive Committee and was responsible for research and development activities worldwide.  In addition to his expanded role as CSO for Caris, Dr. Schorr will continue to serve as a scientific consultant for QIAGEN.

During his 20-year career at QIAGEN, Dr. Schorr led the development of a global R&D function that created many new breakthrough products for use in life sciences research as well as molecular diagnostics. He also played a critical role in the successful integration of new technologies and products into the QIAGEN portfolio. In addition, he played key roles in the integrations of acquired companies, including Genovison, Operon, Artus, DxS, Digene and DxAssays.

Prior to joining QIAGEN, Dr. Schorr worked at Hoechst, the German chemical-pharmaceuticals company, and was involved in the development of an oral malaria vaccine that received the IHK research award in 1991. He was also co-founder of Coley Pharmaceuticals, EnPharma Pharmaceuticals, and QBM Cell Sciences. Dr. Schorr holds a PhD in Molecular Biology and Virology from the University of Cologne.

"The value that Joachim brings to Caris through his extensive scientific and business experiences in the industry as well as his key strategic insights have been clearly evident to our organization over this past year," said David D. Halbert , Chairman and Chief Executive Officer of Caris Life Sciences. "In his official capacity as Chief Scientific Officer, we look forward to Joachim making significant contributions to further advance our innovative technology platforms – platforms that will fundamentally change the way medicine is practiced. We are very pleased to officially welcome him to the Caris Life Sciences team."

About Caris Life Sciences
Caris Life Sciences is a leading biosciences company focused on fulfilling the promise of personalized medicine. Caris' Molecular Intelligence™ Service (MI Profile™) correlates molecular data generated from a patient's tumor with biomarker/drug associations derived from the world's leading clinical cancer literature. This service uses the most advanced and clinically-relevant technologies to provide physicians with information to aid in the selection of personalized cancer treatments more likely to work for each patient. Caris is also developing a series of blood tests based on the company's proprietary Carisome® platform — a blood-based testing technology for diagnosis, prognosis, and theranosis of cancer and other complex diseases. Headquartered in the Dallas metroplex, Caris Life Sciences offers services throughout the United States, Europe, and other international markets. To learn more, please visit www.carislifesciences.com.


'/>"/>
SOURCE Caris Life Sciences
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. TCS Named as a Leader in Life Science Drug Safety Services by Leading Industry Research Firm
2. Prime Therapeutics named a 2013 National Top Workplace
3. Rafarma Pharmaceuticals, Inc. Named 1 Of 4 National Strategic Pharmaceutical Suppliers To The Russian Federation
4. Cohera Medical Named Winner of 2013 Carnegie Science Award
5. PharmaNet/i3 Renamed inVentiv Health Clinical
6. Randy Gaboriault of Christiana Care Health System Named Computerworld Premier 100 IT Leader
7. Heraeus Named "Supplier of the Year" by National Association of Dental Laboratories
8. AbbVie Named to S&P 500 Dividend Aristocrat Index
9. Roche Diagnostics Named to FORTUNE magazines 2013 list of "100 Best Companies to Work For"
10. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
11. Kareo Named a Top Workplace by the Orange County Register
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... , July 10, 2017 The Institute for ... methods, is the recipient of a VITROCELL® inhalation exposure ... International Science Consortium. The device, which is designed to ... expose human lung cells to airborne test materials in ... use the VITROCELL® system for testing combustible tobacco products, ...
(Date:7/6/2017)... division of Diplomat Specialty Infusion Group, is celebrating a decade of empowering ... celebrate its anniversary, ThriveRx recently launched a redesigned website at thriverx.diplomat.is ... to create the best user experience for consumers and health care professionals. ... Diplomat Pharmacy ... "We,ve made several great strides throughout the past 10 years," ...
(Date:7/5/2017)... , July 5, 2017   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade cell and ... media ("BioLife"), today announced that it has reached ... holder and largest shareholder, to modify its existing credit ... to the modification, WAVI agreed to exchange its existing ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... The Margarian Law Firm has filed ... of its ginger ale for allegedly containing no ginger. Dr. Pepper produces the “Canada ... Inc., plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims on its bottle that ...
(Date:7/21/2017)... MO (PRWEB) , ... July 21, 2017 , ... “Kids ... knowing how to tie their shoes,” says Suzanne Tucker, Founder of St. Louis-based positive ... Time-In Toolkit, which launches on Kickstarter on Monday, July 21st. , The kit ...
(Date:7/21/2017)... ... July 21, 2017 , ... The ... offer patients improved quality of life five years after injury, according to research ... Meeting in Toronto, Ontario, Canada. The study followed patients for five years following ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... of blood and bone marrow cancer that progresses rapidly without treatment. Newly diagnosed ... to reduce the chance of reoccurrence and relapse. With such a challenging ...
(Date:7/20/2017)... New York (PRWEB) , ... July 20, 2017 ... ... has developed a telemedicine platform, in which their iMedSecure™ comes included with each ... both share encrypted live images to remote participants for real-time collaboration and immediate ...
Breaking Medicine News(10 mins):